After an FDA roundtable raised alarms about antidepressant use in pregnancy, physicians warn the rhetoric could fuel fear, stigma, and dangerous gaps in care.
In a first-of-its-kind RCT, early testosterone access led to an 11.6-point improvement in self-rated health scores among transgender and gender-diverse adults, while delayed-treatment controls showed no significant change.
A recent study found that pregnant women with high anxiety and depression symptoms exhibited a richer oral microbiome, suggesting potential ways to improve maternal psychological well-being.
"As we continue to learn about the potential harms and benefits of prenatal cannabis use, clinicians must provide coordinated, nonstigmatizing care and education to support pregnant individuals in making informed decisions about cannabis use," noted study authors.